• AngelMed (Shrewsbury, New Jersey) reported the initiation of a Phase II pivotal U.S. trial for the AngelMed Guardian implantable cardiac monitor and alert system. The system is designed to reduce time to presentation by detecting significant changes in the heart's electrical signal and then alerting patients to seek medical attention. The system is comprised of an internal implantable device about the size of a standard pacemaker with a lead into the heart, an external telemetry device, and a programmer that aids physicians in evaluating heart signals.

• CompuMed (Los Angeles) said it will preview its new CompuBridge telecardiology electronic medical records (EMR) solution at the National Conference on Correctional Health Care in Chicago. The CompuBridge EMR is designed to capture and integrate electrocardiogram (ECG) results and over-reads into an existing EMR system. Integration does not require the practice to employ additional software, hardware or specialized servers. CompuBridge EMR will provide users of CompuMed's telecardiology services with the ability to data mine patient records and electronically transfer those records to their own EMR systems, such as patient administrative systems, electronic practice management, laboratory information systems, dietary and pharmacy.

• Tomophase (Burlington, Massachusetts) said that it will display what it said is the first in vivo cross-sectional images of implanted pulmonary stents using their proprietary optical coherence tomography system at the CHEST meeting in Philadelphia. The Tomophase OCT system enables the interventional pulmonologist to visualize sub-epithelial tissue structures in the airway. The system uses a near-infrared emitting probe in a catheter which is integrated with a conventional video bronchoscope. The images captured are from in vivo animal model tracheal tissue. The company said that during the next several months, it plans to continue this work as it progresses towards use of the system in human clinical studies.